Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France (POSTHER)
This study aimed to assess the burden of herpes zoster (HZ) and post-herpetic neuralgia (PHN) among people aged 50 years and older in France, in terms of healthcare resources used, medical direct and indirect costs, as well as pain severity and impact on quality of life. Participants aged 50 years and older who presented to their doctor with their first HZ outbreak were recruited by healthcare providers across France. Over 100 participants completed baseline assessment beginning in 2016. All participants were followed up for 3 months and participants with PHN were also followed up after 6 and 9 months.
Study design
Cohort, Cohort - clinical
Number of participants at first data collection
101 (participants)
Age at first data collection
≥ 50 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2016
Primary Institutions
GlaxoSmithKline (GSK)
Profile paper DOI
Not available
Funders
GlaxoSmithKline (GSK)
Ongoing?
No
Data types collected
- Interview – phone
- Self-report questionnaire – unspecified
- None
- None
- None
Engagement
Keywords
